83
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis

, , , , &
Pages 1015-1029 | Published online: 23 Apr 2019

References

  • Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612–1623. doi:10.1016/S0140-6736(08)60694-718468545
  • Engels T, Baglione Q, Audibert M, et al. Socioeconomic status and stroke prevalence in Morocco: results from the Rabat-Casablanca study. PLoS One. 2014;9(2):e89271. doi:10.1371/journal.pone.008927124586649
  • Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke epidemiology in South, East, and South-East Asia: a review. J Stroke. 2017;19(3):286–294. doi:10.5853/jos.2017.0023429037005
  • Kalkonde YV, Sahane V, Deshmukh MD, et al. High prevalence of stroke in Rural Gadchiroli, India: a community-based Study. Neuroepidemiology. 2016;46(4):235–239. doi:10.1159/00044448726974843
  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi:10.1016/S0140-6736(06)68770-916731270
  • DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi:10.1016/S0140-6736(18)32335-330415748
  • Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603. doi:10.1161/CIR.000000000000048528122885
  • O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi:10.1016/S0140-6736(16)30506-227431356
  • Chen CH, Joshi AU, Mochly-Rosen D. The role of mitochondrial aldehyde dehydrogenase 2 (ALDH2) in neuropathology and neurodegeneration. Acta Neurol Taiwan. 2016;25(4):111–123.28382610
  • Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409(6822):928–933. doi:10.1038/3505714911237013
  • Kitagawa K, Kawamoto T, Kunugita N, et al. Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde; in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse. FEBS Lett. 2000;476(3):306–311.10913633
  • Cichoz-Lach H, Partycka J, Nesina I, et al. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphism in alcohol liver cirrhosis and alcohol chronic pancreatitis among Polish individuals. Scand J Gastroenterol. 2007;42(4):493–498. doi:10.1080/0036552060096572317454860
  • Zhong Z, Hou J, Li B, et al. Genetic polymorphisms of the mitochondrial aldehyde dehydrogenase ALDH2 gene in a large ethnic Hakka population in Southern China. Med Sci Monit. 2018;24:2038–2044.29623947
  • Kang TS, Woo SW, Park HJ, Lee Y, Roh J. Comparison of genetic polymorphisms of CYP2E1, ADH2, and ALDH2 genes involved in alcohol metabolism in Koreans and four other ethnic groups. J Clin Pharm Ther. 2009;34(2):225–230. doi:10.1111/j.1365-2710.2008.00986.x19250143
  • Sun HL. Relationship between ALDH2 polymorphism and the formation of carotid atherosclerotic plaques in cerebral infarction patients (Chinese). J Shandong Univ. 2012;50(7):65–67,73.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b265119622551
  • Niu YM, Weng H, Zhang C, et al. Systematic review by multivariate meta-analyses on the possible role of tumor necrosis factor-alpha gene polymorphisms in association with ischemic stroke. Neuromolecular Med. 2015;17(4):373–384. doi:10.1007/s12017-015-8365-726231680
  • Higgins JP. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158–1160. doi:10.1093/ije/dyn20418832388
  • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.13655060
  • DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med. 1996;15(12):1237–1248; discussion 1249–1252. doi:10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N
  • Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21(11):1559–1573. doi:10.1002/sim.118712111920
  • Xu XJ. Association of ALDH2 gene SNP with cerebral infarction [dissertation]. Accra: Zunyi Medical University; 2012.
  • Zhang CY, Dai YP, Li J, et al. Association between acetaldehyde dehydrogenase 2 gene polymorphism and acute cerebral infarction in Han nationality of Heilongjiang Province (Chinese). Chin J Sch Doctor. 2014;28(5):334–335.
  • Wang GY, Chen NY, Xu YJ. The relationship between genetic polymorphism of aldehyde dehydrogenase-2 and cerebral infarction (Chinese). Chin J Coal Ind Med. 2014;19(1):29–31.
  • Zhou Q. The relationship between ALDH2 gene polymorphisms and susceptibility of ischemic stroke [dissertation]. Accra: Taishan Medical University; 2014.
  • Li QY, Zhao NM, Ma JJ, et al. ALDH2*2 Allele is a negative risk factor for cerebral infarction in Chinese women. Biochem Genet. 2015;53(9–10):260–267. doi:10.1007/s10528-015-9686-926142243
  • Sung YF, Lu CC, Lee JT, et al. Homozygous ALDH2*2 is an independent risk factor for ischemic stroke in Taiwanese men. Stroke. 2016;47(9):2174–2179. doi:10.1161/STROKEAHA.116.01320427486170
  • Sun S, He J, Zhang Y, et al. Genetic polymorphisms in the ALDH2 gene and the risk of ischemic stroke in a Chinese han population. Oncotarget. 2017;8(60):101936–101943. doi:10.18632/oncotarget.2180329254215
  • Qu Y, Zhang HL, Li HY, Yu LM, Sun Y. ALDH2*2 polymorphism is associated with an increased risk of extra cranial vascular stenosis and poor collateral vessels in ischemic stroke in Han Chinese. Int J Clin Exp Med. 2016;9(10):19944–19952.
  • Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke. 2008;39(6):1668–1674. doi:10.1161/STROKEAHA.107.50280718309149
  • Jia Q, Liu LP, Wang YJ. Stroke in China. Clin Exp Pharmacol Physiol. 2010;37(2):259–264. doi:10.1111/j.1440-1681.2009.05290.x19769611
  • Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671. doi:10.1136/bmj.d67121343207
  • Sacco RL. Alcohol and stroke risk: an elusive dose-response relationship. Ann Neurol. 2007;62(6):551–552. doi:10.1002/ana.2129818161056
  • Wassertheil-Smoller S, Kaplan RC, Salazar CR. Stroke findings in the women’s health initiative. Semin Reprod Med. 2014;32(6):438–446. doi:10.1055/s-0034-138462725321421
  • Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30(1):5–13.17718394
  • Zhang R, Wang J, Xue M, Xu F, Chen Y. ALDH2 – the genetic polymorphism and enzymatic activity regulation: their epidemiologic and clinical implications. Curr Drug Targets. 2017;18(15):1810–1816. doi:10.2174/138945011666615072711511826212265
  • Lai CL, Yao CT, Chau GY, et al. Dominance of the inactive Asian variant over activity and protein contents of mitochondrial aldehyde dehydrogenase 2 in human liver. Alcohol Clin Exp Res. 2014;38(1):44–50. doi:10.1111/acer.1221523909789
  • Szocs K, Lassegue B, Wenzel P, et al. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol. 2007;42(6):1111–1118. doi:10.1016/j.yjmcc.2007.03.90417493633
  • Wu B, Yu L, Wang Y, et al. Aldehyde dehydrogenase 2 activation in aged heart improves the autophagy by reducing the carbonyl modification on SIRT1. Oncotarget. 2016;7(3):2175–2188. doi:10.18632/oncotarget.681426741505
  • D’Souza Y, Elharram A, Soon-Shiong R, Andrew RD, Bennett BM. Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer’s disease. Mol Brain. 2015;8:27. doi:10.1186/s13041-015-0117-y25910195
  • Narita M, Kitagawa K, Nagai Y, et al. Effects of aldehyde dehydrogenase genotypes on carotid atherosclerosis. Ultrasound Med Biol. 2003;29(10):1415–1419.14597338
  • Ma XX, Zheng SZ, Shu Y, Wang Y, Chen XP. Association between carotid intima-media thickness and aldehyde dehydrogenase 2 Glu504Lys polymorphism in Chinese Han with essential hypertension. Chin Med J (Engl). 2016;129(12):1413–1418. doi:10.4103/0366-6999.18341327270535
  • Howard DP, van Lammeren GW, Rothwell PM, et al. Symptomatic carotid atherosclerotic disease: correlations between plaque composition and ipsilateral stroke risk. Stroke. 2015;46(1):182–189. doi:10.1161/STROKEAHA.114.00722125477221
  • Network NSG, International Stroke Genetics C. Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol. 2016;15(2):174–184. doi:10.1016/S1474-4422(15)00338-526708676